Metabolic cardiovascular risk burden and atherosclerosis in African black and Caucasian women with rheumatoid arthritis: A cross-sectional study

Clinical and Experimental Rheumatology

Volumn 31, Issue 1, 2013, Pages 53-61

  Dessein, Patrick H ^a   Norton, Gavin R ^a   Joffe, Barry I ^a   Abdool Carrim, Abu T ^b,c   Woodiwiss, Angela J ^a   Solomon, Ahmed ^d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c MILPARK HOSPITAL   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Developing population; Metabolic syndrome; Rheumatoid arthritis

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOMETABOLIC RISK; CAROTID ATHEROSCLEROSIS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WOMEN'S HEALTH;

EID: 84874925790     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. MEUNE C, TOUZE E, TRINQUART L, ALLANORE Y. High risk of clinical cardiovascular events in rheumatoid arthritis. Levels of associations of myocardial infarction and stroke through a systematic review and metaanalysis. Arch Cardiovasc Dis 2010; 103. 253-61.
2. AVINA-ZUBIETA JA, CHOI HK, SADATSAFAVI M, ETMINAN M, ESDAILE JM, LACAILLE D. Risk of cardiovascular mortality in patients with rheumatoid arthritis. a meta-analysis of observational studies. Arthritis Rheum 2008; 59. 1690-7.
3. DESSEIN PH, JOFFE BI, VELLER MG et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005; 32. 435-42.
4. GONZALEZ-GAY MA, GONZALEZ-JUANATAY C, PINEIRO A, GARCIA-PORRUA C, TESTA A, LLORCA J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005; 32. 1219-23.
5. DEL RINCON I, FREEMAN GL, HAAS RW, O'LEARY DH, ESCALANTE A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005; 52. 3413-23.
6. CHUNG CP, OESER A, RAGGI P et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis. relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 2005; 52. 3045-53.
7. ROMAN MJ, MOELLER E, DAVIS A et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006; 144. 249-56.
8. KREMERS HM, CROWSON CS, THEMEAU TM, ROGER VL, GABRIEL SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients. a population-based cohort study. Arthritis Rheum 2008; 58. 2268-74.
9. WOLFE F, MICHAUD K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis. a cohort and nested case-control analysis. Arthritis Rheum 2008; 58. 2612-21.
10. SOLOMON DH, KREMERS J, CURTIS JR et al. Explaining the cardiovascular risk associated with rheumatoid arthritis. traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010; 69. 1920-5.
11. SCOTT IC, IBRAHIM F, JOHNSON D, SCOTT DL, KINGSLEY GH. Current limitations in the management of cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol 2012; 30. 228-32.
12. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, LOPEZ-DIAZ MJ et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57. 125-32.
13. TOMS TE, PANOULOS VF, SMITH JP et al. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis. Ann Rheum Dis 2011; 70. 1025-32.
14. ARLESTIG L, WALLBERG-JONSSON S, STEGMAYR B, RANTAAPA-DAHLQVIST S. Polymorphisms of genes related to cardiovascular disease in patients with rheumatoid arthritis. Clin Exp Rheumatol 2007; 25. 866-71.
15. PAALOMINO-MORALES R, GONZALEZ-JUANATEY C, VAZQUEZ-RODRIGUEZ TR et al. Interleukin-6 gene-174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol 2009; 27. 964-70.
16. DESSEIN PH, STANWIX AE, JOFFE BI. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis. acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002; 4. R5.
17. DESSEIN PH, JOFFE BI, STANWIX AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 2004; 6. 443-6.
18. DESSEIN PH, TOBIAS M, VELLER MG. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 2006; 33. 2425-32.
19. KARVOUNARIS SA, SIDIROPOULOS PI, PAPADAKIS JA et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity. a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 2007; 66. 28-33.
20. CHUNG CP, OESER A, SOLUS JF et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008; 196. 758-63.
21. TOMS TE, PANOULAS VF, JOHN H, DOUGLAS KMJ, KITAS GD. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60 - more than just an anti-inflammatory effect A cross sectional study. Arthritis Res Ther 2009; 11. R110.
22. DAO H-H, DO Q-T, SAKAMOTO J. Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis. a cross-sectional study. Arthritis Res Ther 2010; 12. R218.
23. GONZALEZ-GAY MA, GONZALEZ-JANATEY C, VAZQUEZ-RODRIGUEZ TR, MIRANDAFILLOY JA, LLORCA J. Insulin resistance in rheumatoid arthritis. the impact of the anti-TNF-alpha therapy. Ann N Y Acad Sci 2010; 1193. 153-9.
24. CROWSON CS, MYASOEDOVA E, DAVIS III JM et al. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol 2011; 38. 29-35.
25. GILES JT, ALLISON M, BLUMENTHAL RS et al. Abdominal adiposity in rheumatoid arthritis. association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 2010; 62. 3173-82.
26. GONZALEZ-GAY MA, LLORCA J, GARCIAUNZUETA MT et al. High-grade inflammation, circulating adiponectin concentrations, and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol 2008; 26. 596-603.
27. PAMUK ON, UNLU E, CAKIR N. Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis. J Rheumatol 2006; 33. 2447-52.
28. YUSUF S, HAWKEN S, OUNPUU S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). casecontrol study. Lancet 2004; 364. 937-52.
29. SOLOMON A, CHRISTIAN BF, NORTON GR, WOODIWISS AJ, DESSEIN PH. Risk factor profiles for atherosclerotic cardiovascular disease in black and other Africans with established rheumatoid arthritis. J Rheumatol 2010; 37. 953-60.
30. SOLOMON L, ROBIN G, VALKENBURG HA. Rheumatoid arthritis in an urban South African Negro population. Ann Rheum Dis 1979; 34. 128-35.
31. YUSUF S, REDDY S, OUNPUU S, ANAND S. Global burden of cardiovascular diseases, Part 1. General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104. 2746-53.
32. STEYN K, SLIWA K, HAWKEN S et al. Risk factors associated with myocardial infarction in Africa. The INTERHEART Africa Study. Circulation 2005; 112. 3554-61.
33. BHORAT H. South Africa has the widest gap between rich and poor. Sept 28 2009. (accessed 1 Oct 2010).
34. MAYOSI BM, FLISHER AJ, LALLO UG, SITAS F, TOLLMAN SM, BRADSHAW D. The burden of non-communicable diseases in South Africa. Lancet 2009; 374. 934-47.
35. SOLOMON A, CHRISTIAN BF, WOODIWISS AJ, NORTON GR, DESSEIN PH. Burden of depressive symptoms in South African public healthcare patients with established rheumatoid arthritis. a case-control study. Clin Exp Rheumatol 2011; 29. 506-12.
36. PUOANE T, STEYN K, BRADSHAW D et al. Obesity in South Africa. the South African demographic and health survey. Obes Res 2002; 10. 1038-48.
37. MOTALA AA, ESTERHUIZEN T, PIRIE FG, OMAR MA. The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diabetes Care 2011; 34. 1032-7.
38. SLIWA K, WILKINSON D, HANSEN C et al. Spectrum of heart disease and risk factors in an urban population in South Africa (Heart of Soweto Study). a cohort study. Lancet 2008; 317. 915-22.
39. GRUNDY SM, CLEEMAN JI, DANIEL SR et al. Diagnosis and management of the metabolic syndrome. an American Heart Association/ National Heart, Lung, and blood Institute Scientific Statement. Executive summary. Circulation 2005; 112. e285-90.
40. GONZALEZ-JUANATEY C, LLORCA J, MARTIN J, GONZALEZ-GAY MA. Carotid intimamedia thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009; 38. 366-71.
41. EVANS MR, ESCALANTE A, BATTAFARANO DF, FREEMAN GL, O'LEARY DH, DEL RINCON I. Carotid atherosclerosis predicts incident acute coronary syndrome in rheumatoid arthritis. Arthritis Rheum 2011; 63. 1211-20.
42. ARNETT FC, EDWORTHY SM, BLOCH DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31. 315-24.
43. DESSEIN PH, CHRISTIAN BF, SOLOMON A. Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context J Rheumatol 2009; 36. 357-61.
44. DESSEIN PH, CHRISTIAN BF, WOODIWISS AJ, NORTON GR, SOLOMON A. Public healthcare attendance associates with enhanced conventional and non-conventional atherosclerotic cardiovascular disease risk burdens in established rheumatoid arthritis. Clin Exp Rheumatol 2010; 28. 230-7.
45. GEPNER AD, KORCARZ CE, AESCHLIMANN SE et al. Validation of a carotid intima-media thickness border detection program for use in an office setting. J Am Soc Echocardiogr 2006; 19. 223-8.
46. TOUBOUL PJ, HENNERICI MG, MEAIRS S et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23. 75-80.
47. SIMON A, MEGNIEN J-L, CHIRONI G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Biol 2010; 30. 182-5.
48. RICCIO SA, HOUSE AA, SPENCE JD, FENSTER A, PARRAGA G. Carotid ultrasound phenotypes in vulnerable populations. Cardiovasc Ultrasound 2006, 4. 44.
49. JOHNSEN SH, MATHIESEN EB, JOAKIMSEN O et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men. a 6-year follow-up study of 6226 persons. The Tromso. Stroke 2007; 38. 2873-80.
50. EBAHIM S, PAPACOSTA O, WHINCUP P et al. Carotid plaque, intima-media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women. The British Regional Heart Study. Stroke 1999; 30. 841-50.
51. SPENCE JD, HEGELE RA. Noninvasive phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24. e188.
52. JOHNSEN SH, MATHIESWEN EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 2009; 11. 21-7.
53. BELCARO G, NICOLAIDES AN, RAMASWAMI G et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects. a 10-year follow-up study (the CAFES-CAVES study [1]). Atherosclerosis 2001; 156. 379-87.
54. WALKER ARP, SARELI P. Coronary heart disease. outlook for Africa. J R Soc 1997; 90. 23-7.
55. CHIRINOS JA, KIPS JG, ROMAN MJ et al. Ethnic differences in arterial wave reflections and normative equations for augmentation index. Hypertension 2011; 57. 1108-16.
56. MASEKO MJ, WOODIWISS AJ, MAJANE OH, MOLEBATSI N, NORTON GR. Marked underestimation of blood pressure control with conventional vs. ambulatory measurements in an urban, developing community of African ancestry. Am J Hypertens 2011; 24. 789-95.